Corpus 1,273 assessed · 1,174 scored · 643 reproduced ≥75 · 169 flagged ·∅ 74.1/100

Publications 1 Datasets 392.5k Experiments 4.7k

Explore

Filters: 2025 ✕ Chemotherapy ✕ clear all

1 matching publication(s)

Publication	Journal	Year	Score	Verdict
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses. PMID 40128415	Breast Cancer	2025	71	L1 71/100

IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses.

PMID 40128415 · Breast Cancer · 2025

L1 71/100